Abstract:Therapeutic protein production in plants is an area of great potential for increasing and improving the production of proteins for the treatment or prevention of disease in humans and other animals. There are a number of key benefits of this technique for scientists and society, as well as regulatory challenges that need to be overcome by policymakers. Increased public understanding of the costs and benefits of therapeutic protein production in plants will be instrumental in increasing the acceptance, and thus the medical and veterinary impact, of this approach. Therapeutic recombinant proteins are a powerful tool for combating many diseases which have previously been hard to treat. The most utilized expression systems are Chinese Hamster Ovary cells and Escherichia coli, but all available expression systems have strengths and weaknesses regarding development time, cost, protein size, yield, growth conditions, posttranslational modifications and regulatory approval. The plant industry is well established and growing and harvesting crops is easy and affordable using current infrastructure. Growth conditions are generally simple: sunlight, water, and the addition of cheap, available fertilizers. There are multiple options for plant expression systems, including species, genetic constructs and protein targeting, each best suited to a particular type of therapeutic protein production. Transient expression systems provide a mechanism to rapidly transfect plants and produce therapeutic protein in a matter of weeks, rather than the months it can take for many competing expression systems, while proteins targeted to cereal seeds can be harvested, stored and potentially purified much more easily than in competing systems. Current challenges for plant expression systems include a lack of regulatory approval, environmental containment concerns and nonhuman glycosylation, which may limit the scope of the type of therapeutic proteins that can be manufactured in plants. The specific strengths of plant expression systems could facilitate the production of certain therapeutic proteins quickly and cheaply in the near future. Therapeutic protein production in plants is an area of great potential for increasing and improving the production of proteins for the treatment or prevention of disease in humans and other animals. There are a number of key benefits of this technique for scientists and society, as well as regulatory challenges that need to be overcome by policymakers. Increased public understanding of the costs and benefits of therapeutic protein production in plants will be instrumental in increasing the acceptance, and thus the medical and veterinary impact, of this approach.

Green Biologics: Harnessing the Power of Plants to Produce Pharmaceuticals

Maximizing the Production of Recombinant Proteins in Plants: from Transcription to Protein Stability

Green biotherapeutics: overcoming challenges in plant-based expression platforms

Plant-produced biopharmaceuticals: A case of technical developments driving clinical deployment

Green biofactories: recombinant protein production in plants

The production of biopharmaceuticals in plant systems

Recent advances in expression and purification strategies for plant made vaccines

Therapeutically important proteins from in vitro plant tissue culture systems

Biopharmaceutical production in plants: problems, solutions and opportunities

Plant-based biopharmaceutical engineering

Plant-based solutions for veterinary immunotherapeutics and prophylactics

Improving Protein Quantity and Quality-The Next Level of Plant Molecular Farming

Plant cell-based drug delivery enhances affordability of biologics

Plant-made pharmaceuticals: exploring studies for the production of recombinant protein in plants and assessing challenges ahead

Plant-based expression platforms to produce high-value metabolites and proteins

Plant-made vaccine antigens and biopharmaceuticals

Cellular engineering of plant cells for improved therapeutic protein production

Review of Recombinant Therapeutic Protein Expression in Transgenic Plants

Green (cell) factories for advanced production of plant secondary metabolites

Exploring recent progress of molecular farming for therapeutic and recombinant molecules in plant systems

Therapeutic recombinant protein production in plants: Challenges and opportunities